Among insured women, aged 19–26 years, those who discussed the HPV vaccine with their
physician and received a recommendation were overwhelmingly more likely to be …

Background Despite national recommendations, as of 2009 human papillomavirus (HPV)
vaccination rates were low with< 30% of adolescent girls fully vaccinated. Research on …

Drawing on 38 in-depth qualitative interviews with college women and college health
clinicians, we collected human papillomavirus (HPV) vaccine decision narratives to identify …

Infection with a high-risk type of the human papillomavirus (HPV) is a major contributing
factor in the vast majority of cervical cancers. Dissemination of the HPV vaccine is critical in …

We evaluated the characteristics associated with uptake of HPV vaccine by 19–26 year old
women seen in primary care university-based clinics. Of the 11,545 women analyzed only …

The vaccinology landscape has changed, with national authorities now being increasingly
accountable to new stakeholders such as health insurers, regional regulatory bodies, the …

BACKGROUND: Since 2006, the human papillomavirus (HPV) vaccine has been routinely
recommended for preadolescent and adolescent girls in the United States. Depending on …

BACKGROUND: Despite the benefit of the human papillomavirus (HPV) vaccine in
preventing cervical cancer, fewer than half of eligible young women in the United States …

OBJECTIVES:(1) Describe content and character of patient–physician human papilloma
virus (HPV) vaccine discussions;(2) explore the relationship between selected …

The authors performed telephone interviews of parents of adolescents (n= 430) and their
older adolescents (n= 208) in Monroe County, New York to measure parent and adolescent …